| Literature DB >> 19528256 |
Simona Greco1, Marco De Simone, Claudia Colussi, Germana Zaccagnini, Pasquale Fasanaro, Mario Pescatori, Rosanna Cardani, Riccardo Perbellini, Eleonora Isaia, Patrizio Sale, Giovanni Meola, Maurizio C Capogrossi, Carlo Gaetano, Fabio Martelli.
Abstract
The aim of this work was to identify micro-RNAs (miRNAs) involved in the pathological pathways activated in skeletal muscle damage and regeneration by both dystrophin absence and acute ischemia. Eleven miRNAs were deregulated both in MDX mice and in Duchenne muscular dystrophy patients (DMD signature). Therapeutic interventions ameliorating the mdx-phenotype rescued DMD-signature alterations. The significance of DMD-signature changes was characterized using a damage/regeneration mouse model of hind-limb ischemia and newborn mice. According to their expression, DMD-signature miRNAs were divided into 3 classes. 1) Regeneration miRNAs, miR-31, miR-34c, miR-206, miR-335, miR-449, and miR-494, which were induced in MDX mice and in DMD patients, but also in newborn mice and in newly formed myofibers during postischemic regeneration. Notably, miR-206, miR-34c, and miR-335 were up-regulated following myoblast differentiation in vitro. 2) Degenerative-miRNAs, miR-1, miR-29c, and miR-135a, that were down-modulated in MDX mice, in DMD patients, in the degenerative phase of the ischemia response, and in newborn mice. Their down-modulation was linked to myofiber loss and fibrosis. 3) Inflammatory miRNAs, miR-222 and miR-223, which were expressed in damaged muscle areas, and their expression correlated with the presence of infiltrating inflammatory cells. These findings show an important role of miRNAs in physiopathological pathways regulating muscle response to damage and regeneration.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19528256 DOI: 10.1096/fj.08-128579
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191